These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36714799)

  • 1. Molecular insights into onset of autoimmunity in SARS-CoV-2 infected patients.
    Laxminarayana D
    Rheumatol Autoimmun; 2022 Dec; 2(4):198-202. PubMed ID: 36714799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection as a trigger of autoimmune response.
    Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
    Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SARS-CoV-2 as an instrumental trigger of autoimmunity.
    Dotan A; Muller S; Kanduc D; David P; Halpert G; Shoenfeld Y
    Autoimmun Rev; 2021 Apr; 20(4):102792. PubMed ID: 33610751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
    Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
    Front Immunol; 2020; 11():1949. PubMed ID: 32849654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.
    Saheb Sharif-Askari N; Saheb Sharif-Askari F; Ahmed SBM; Hannawi S; Hamoudi R; Hamid Q; Halwani R
    Front Immunol; 2021; 12():686462. PubMed ID: 34276672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets.
    Bellucci G; Ballerini C; Mechelli R; Bigi R; Rinaldi V; Reniè R; Buscarinu MC; Baranzini SE; Madireddy L; Matarese G; Salvetti M; Ristori G
    F1000Res; 2020; 9():992. PubMed ID: 33456761
    [No Abstract]   [Full Text] [Related]  

  • 7. SARS-CoV-2 triggering autoimmune diseases.
    Mobasheri L; Nasirpour MH; Masoumi E; Azarnaminy AF; Jafari M; Esmaeili SA
    Cytokine; 2022 Jun; 154():155873. PubMed ID: 35461172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Tolerance Broken in Autoimmunity?
    Laxminarayana D
    Clin Med Insights Pathol; 2017; 10():1179555717712716. PubMed ID: 28579863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mimicry between SARS-CoV-2 and Human Endocrinocytes: A Prerequisite of Post-COVID-19 Endocrine Autoimmunity?
    Churilov LP; Normatov MG; Utekhin VJ
    Pathophysiology; 2022 Aug; 29(3):486-494. PubMed ID: 36136066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.
    Vahabi M; Ghazanfari T; Sepehrnia S
    Int Immunopharmacol; 2022 Nov; 112():109183. PubMed ID: 36182877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies.
    Damoiseaux J; Dotan A; Fritzler MJ; Bogdanos DP; Meroni PL; Roggenbuck D; Goldman M; Landegren N; Bastard P; Shoenfeld Y; Conrad K
    Autoimmun Rev; 2022 Mar; 21(3):103012. PubMed ID: 34896650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes.
    Moody R; Sonda S; Johnston FH; Smith KJ; Stephens N; McPherson M; Flanagan KL; Plebanski M
    Front Immunol; 2022; 13():945021. PubMed ID: 36032086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and autoimmune diseases.
    Liu Y; Sawalha AH; Lu Q
    Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens.
    Ulndreaj A; Wang M; Misaghian S; Paone L; Sigal GB; Stengelin M; Campbell C; Van Nynatten LR; Soosaipillai A; Ghorbani A; Mathew A; Fraser DD; Diamandis EP; Prassas I
    Clin Chem Lab Med; 2022 Jun; 60(7):1116-1123. PubMed ID: 35475723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T Cell Receptor Sequences Amplified during Severe COVID-19 and Multisystem Inflammatory Syndrome in Children Mimic SARS-CoV-2, Its Bacterial Co-Infections and Host Autoantigens.
    Root-Bernstein R; Churchill E; Oliverio S
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation.
    Darmarajan T; Paudel KR; Candasamy M; Chellian J; Madheswaran T; Sakthivel LP; Goh BH; Gupta PK; Jha NK; Devkota HP; Gupta G; Gulati M; Singh SK; Hansbro PM; Oliver BGG; Dua K; Chellappan DK
    Environ Sci Pollut Res Int; 2022 Aug; 29(36):54072-54087. PubMed ID: 35657545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies targeting cytokines and connective tissue disease autoantigens are common in acute non-SARS-CoV-2 infections.
    Feng A; Yang E; Moore A; Dhingra S; Chang S; Yin X; Pi R; Mack E; Völkel S; Geßner R; Gundisch M; Neubauer A; Renz H; Tsiodras S; Fragkou P; Asuni A; Levitt J; Wilson J; Leong M; Lumb J; Mao R; Pinedo K; Roque J; Richards C; Stabile M; Swaminathan G; Salagianni M; Triantafyllia V; Bertrams W; Blish C; Carette J; Frankovich J; Meffre E; Nadeau KC; Singh U; Wang T; Prak EL; Herold S; Andreakos E; Schmeck B; Skevaki C; Rogers A; Utz P
    Res Sq; 2022 Jan; ():. PubMed ID: 35075455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
    Moody R; Wilson K; Flanagan KL; Jaworowski A; Plebanski M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.